Chembio Diagnostic, Inc. Banner Image

Chembio Diagnostic, Inc. has reached its limit for free report views

Work for Chembio Diagnostic, Inc.? Upgrade Your Profile and unlock all your annual reports.

Chembio Diagnostic, Inc.

  • Ticker CEMI
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Chembio Diagnostic, Inc. Logo Image
  • 51-200 Employees
  • Based in Medford, New York
Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets each of its DPP HIV 1/2 Assay, HIV 1/2 STAT-PAK Assay, and SURE CHECK HIV 1/2 Assay, with these Chembio brand names, in the U.S. and internationally both directly and through third-party distributors. The Company'sMore SURE CHECK HIV 1/2 Assay previously has been exclusively sold in the U.S. as Clearview Complete HIV 1/2 Assay.
Chembio Diagnostic, Inc.

Most Recent Annual Report

Chembio Diagnostic, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. Chembio Diagnostic, Inc. has reached its limit for free report views.

Chembio Diagnostic, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports